本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Immunovant, Inc.

15.20
-1.8900-11.06%
盘后15.10-0.1000-0.66%19:58 EDT
成交量:371.15万
成交额:5,809.54万
市值:25.82亿
市盈率:-5.81
高:17.09
开:17.06
低:15.00
收:17.09
数据加载中...

公司资料

公司名字:
Immunovant, Inc.
交易所:
NASDAQ
成立时间:
- -
员工人数:
207
公司地址:
320 West 37th Street,6th Floor,New York,New York,United States
邮编:
10018
电话:
传真:
- -
简介:
Immunovant, Inc.于2018年12月6日在特拉华州注册成立,是一家临床阶段生物制药公司,专注于为自身免疫性疾病患者提供正常生活。

董事

名称
职位
Peter Salzmann
Chief Executive Officer,Director
Frank M. Torti
Director,Executive Chairperson of the Board
Andrew Fromkin
Director
Atul Pande
Director
Douglas Hughes
Director
Eric Venker
Director
George Migausky
Director

股东

名称
职位
Peter Salzmann
Chief Executive Officer,Director
Eva Renee Barnett
Chief Financial Officer
Jay S. Stout
Chief Technology Officer
Julia G. Butchko
Chief Development Officer
Mark S. Levine
Chief Legal Officer and Corporate Secretary
William L. Macias
Chief Medical Officer